Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.412 SEK | -2.49% | -4.98% | -68.93% |
Feb. 23 | Kancera AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 23 | Kancera AB Signs A License Agreement with the University of Newcastle | CI |
Sales 2023 | 1.03M 94.61K | Sales 2024 * | - | Capitalization | 171M 15.64M |
---|---|---|---|---|---|
Net income 2023 | -64M -5.85M | Net income 2024 * | -81M -7.4M | EV / Sales 2023 | 358 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 |
-9.28
x | P/E ratio 2024 * |
-2.02
x | Employees | 3 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 37.38% |
1 day | -2.49% | ||
1 week | -4.98% | ||
Current month | -17.52% | ||
1 month | -28.90% | ||
3 months | -66.70% | ||
6 months | -62.04% | ||
Current year | -68.93% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Selin
CEO | Chief Executive Officer | - | 22-02-28 |
Director of Finance/CFO | 75 | - | |
Martin Norin
COO | Chief Operating Officer | 65 | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 10-05-04 | |
Director/Board Member | 66 | 15-12-31 | |
Håkan Mellstedt
FOU | Founder | 82 | 10-04-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.412 | -2.49% | 234,632 |
24-04-25 | 1.448 | -1.36% | 388,097 |
24-04-24 | 1.468 | -1.87% | 362,923 |
24-04-23 | 1.496 | -0.27% | 277,239 |
24-04-22 | 1.5 | +0.94% | 249,994 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.93% | 15.61M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KAN Stock